(Q38471926)

English

Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.

scientific article published on 10 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Silverio Perrotta

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Maria Domenica Cappellini

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Giovanni Iolascon

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Gian Luca Forni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Andrea Giusti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Giovanni Quarta

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Lorella Pitrolo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Domenico Giuseppe D'Ascola

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Caterina Borgna Pignatti

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Paolo Rigano

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Aldo Filosa

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Bruno Nobili

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Marina Baldini

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Alessandra Rosa

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Valeria Pinto

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Ernesto Palummeri

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

0 references

publication date

10 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

158

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

274-282

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22571408%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Intravenous neridronate in adults with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Intramuscular neridronate in postmenopausal women with low bone mineral density.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

The Italian SF-36 Health Survey: translation, validation and norming

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Hypogonadism and Hormone Replacement Therapy on Bone Mass of Adult Women with Thalassemia Major

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Effects of neridronate treatment in elderly women with osteoporosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Long-term effects of neridronate on human osteoblastic cell cultures.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Neridronic acid for the treatment of bone metabolic diseases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Bisphosphonates in the treatment of thalassemia-associated osteoporosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Atypical fractures of the femur and bisphosphonate therapy: A systematic review of case/case series studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Bone disease and skeletal complications in patients with β thalassemia major

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

High prevalence of low bone mass in thalassaemia major.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Long-term effects of pamidronate in thalassemic patients with severe bone mineral density deficits

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Bisphosphonates in the treatment of thalassemia-induced osteoporosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Bone density, mineral content, and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Treatment of beta-thalassaemia-associated osteoporosis with zoledronic acid.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

BONE MINERAL DENSITY IN IRANIAN ADOLESCENTS AND YOUNG ADULTS WITH β-THALASSEMIA MAJOR

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

The morbidity of bone disease in thalassemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Low bone mineral density in adolescents with beta-thalassemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Evaluating translations of health status questionnaires. Methods from the IQOLA project. International Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Clinical management of beta-thalassemia major

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Oxidative stress-induced DNA damage in the synovial cells of the temporomandibular joint in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Drug-induced esophagitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Intravenous Neridronate in Children With Osteogenesis Imperfecta: A Randomized Controlled Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09152.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38471926&oldid=1508731580"